Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 10701-10750 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05000840
Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA
N/A
Active, not recruiting
750 participants
Started: Oct 20, 2021 · Completed: Mar 31, 2025
2 conditions
3 sponsors
1 location
NCT05044897
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
PHASE2
Active, not recruiting
11 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT05121519
Does Eliminating Coffee Avoid Fibrillation?
NA
Active, not recruiting
200 participants
Started: Oct 20, 2021 · Completed: Oct 20, 2025
2 conditions
1 sponsor
3 locations
NCT05118828
Guided Internet-based Interventions in Primary Care Effectiveness-implementation Randomized Controlled Trial
NA
Active, not recruiting
1,000 participants
Started: Oct 20, 2021 · Completed: Jun 30, 2026
2 conditions
6 sponsors
6 locations
NCT05974826
Healthy Communities: a Healthy City Preventive Program on Cardiovascular Health and Well-being (HC)
NA
Active, not recruiting
2,000 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2030
3 conditions
3 sponsors
1 location
NCT04927689
Evaluation of an Environmental Counsellor's Home Stay in Children Treated for Asthma or Allergic Rhinitis Via a Standardized Medical Questionnaire Randomized Controlled Superiority Trial in Parallel Arms, Multicentric (EvalPCE)
N/A
Active, not recruiting
100 participants
Started: Oct 20, 2021 · Completed: Jan 15, 2026
1 condition
1 sponsor
1 location
NCT05500846
Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial
NA
Active, not recruiting
51 participants
Started: Oct 19, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
2 locations
NCT05516810
The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles
N/A
Active, not recruiting
500 participants
Started: Oct 19, 2021 · Completed: Sep 30, 2024
5 conditions
2 sponsors
2 locations
NCT04546620
Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
PHASE2
Active, not recruiting
453 participants
Started: Oct 19, 2021 · Completed: May 31, 2028
1 condition
2 sponsors
33 locations
NCT05062031
Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops
NA
Active, not recruiting
242 participants
Started: Oct 19, 2021 · Completed: Feb 28, 2026
1 condition
3 sponsors
1 location
NCT04986566
Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
NA
Active, not recruiting
134 participants
Started: Oct 19, 2021 · Completed: Feb 7, 2026
1 condition
3 sponsors
1 location
NCT05044546
A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers
NA
Active, not recruiting
26 participants
Started: Oct 19, 2021 · Completed: Mar 31, 2026
2 conditions
5 sponsors
1 location
NCT04668001
Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome
NA
Active, not recruiting
19 participants
Started: Oct 19, 2021 · Completed: Sep 1, 2024
1 condition
1 sponsor
1 location
NCT03865160
Low-dose Atropine for Myopia Control in Children
PHASE2/PHASE3
Active, not recruiting
302 participants
Started: Oct 19, 2021 · Completed: Nov 30, 2027
1 condition
1 sponsor
19 locations
NCT04809376
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
PHASE2/PHASE3
Active, not recruiting
602 participants
Started: Oct 19, 2021 · Completed: Jan 6, 2025
1 condition
1 sponsor
33 locations
NCT05066997
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
PHASE2/PHASE3
Active, not recruiting
552 participants
Started: Oct 19, 2021 · Completed: Apr 30, 2026
1 condition
1 sponsor
52 locations
NCT05100472
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
PHASE2
Active, not recruiting
50 participants
Started: Oct 19, 2021 · Completed: Oct 19, 2025
1 condition
1 sponsor
7 locations
NCT04584320
Identification of Clostridium Butyricum and Clostridium Neonatal in the Digestive Microbiota of Premature Infants Before 34 Weeks and Developing or Not Ulcerative Necrotizing Enterocolitis (NEC) During Hospitalization
N/A
Active, not recruiting
40 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05057182
Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)
PHASE4
Active, not recruiting
300 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05104866
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
PHASE3
Active, not recruiting
732 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
167 locations
NCT04795661
Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.
PHASE2
Active, not recruiting
240 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2029
2 conditions
1 sponsor
17 locations
NCT05081492
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
PHASE1
Active, not recruiting
9 participants
Started: Oct 18, 2021 · Completed: Mar 30, 2026
3 conditions
3 sponsors
1 location
NCT05577000
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
PHASE1
Active, not recruiting
5 participants
Started: Oct 18, 2021 · Completed: Oct 1, 2043
2 conditions
4 sponsors
1 location
NCT05092542
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
NA
Active, not recruiting
1,212 participants
Started: Oct 18, 2021 · Completed: Jul 31, 2026
4 conditions
2 sponsors
1 location
NCT04961762
Navigator Program for Homeless Adults
NA
Active, not recruiting
656 participants
Started: Oct 18, 2021 · Completed: Aug 1, 2025
4 conditions
2 sponsors
1 location
NCT04673448
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
PHASE1
Active, not recruiting
18 participants
Started: Oct 18, 2021 · Completed: Sep 30, 2026
27 conditions
2 sponsors
1 location
NCT05065008
The Roles of Gut Microbiome in UTI Susceptible Women
NA
Active, not recruiting
160 participants
Started: Oct 18, 2021 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT05162755
S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers
PHASE1
Active, not recruiting
51 participants
Started: Oct 15, 2021 · Completed: Jun 19, 2025
1 condition
2 sponsors
5 locations
NCT04708418
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
PHASE2
Active, not recruiting
60 participants
Started: Oct 15, 2021 · Completed: Jun 30, 2026
6 conditions
1 sponsor
188 locations
NCT04806061
Urine Alkalinisation in COVID-19
NA
Active, not recruiting
80 participants
Started: Oct 15, 2021 · Completed: Jul 30, 2024
2 conditions
2 sponsors
2 locations
NCT05123144
A Hybrid Type II Trial of the Optimizing Resilience and Coping With HIV Through Internet Delivery in Ryan White Clinics in Chicago
PHASE2
Active, not recruiting
300 participants
Started: Oct 15, 2021 · Completed: Dec 31, 2025
1 condition
3 sponsors
3 locations
NCT04811287
PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome
NA
Active, not recruiting
46 participants
Started: Oct 15, 2021 · Completed: Dec 28, 2026
2 conditions
1 sponsor
1 location
NCT05422742
Influence of SRP With MM on the Composition and Functional Characteristics of Subgingival Microbiome Communities
NA
Active, not recruiting
50 participants
Started: Oct 15, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05158322
Effectiveness of the Decolonization Circuit of S. Aureus, Reducing Infection in Primary Arthroplasty of the Lower Limb
N/A
Active, not recruiting
90 participants
Started: Oct 14, 2021 · Completed: May 30, 2025
3 conditions
1 sponsor
1 location
NCT05069974
Alternative Antibiotics for Syphilis
PHASE3
Active, not recruiting
224 participants
Started: Oct 14, 2021 · Completed: Apr 30, 2026
3 conditions
1 sponsor
6 locations
NCT04662879
Early Detection Initiative for Pancreatic Cancer
NA
Active, not recruiting
8,869 participants
Started: Oct 14, 2021 · Completed: Jan 31, 2028
3 conditions
1 sponsor
2 locations
NCT05059262
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
PHASE3
Active, not recruiting
123 participants
Started: Oct 14, 2021 · Completed: Jul 31, 2026
5 conditions
1 sponsor
35 locations
NCT04848038
Combined Exercise Trial
NA
Active, not recruiting
280 participants
Started: Oct 14, 2021 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT05057247
Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
PHASE2
Active, not recruiting
26 participants
Started: Oct 14, 2021 · Completed: Jan 1, 2026
5 conditions
2 sponsors
1 location
NCT04455750
A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy
PHASE3
Active, not recruiting
61 participants
Started: Oct 14, 2021 · Completed: Sep 30, 2027
5 conditions
2 sponsors
414 locations
NCT06750471
Dupixent Study for Alternate Administration
PHASE4
Active, not recruiting
30 participants
Started: Oct 14, 2021 · Completed: Dec 31, 2025
3 conditions
4 sponsors
1 location
NCT06522139
Clinical Outcome After Episealer Talus Implant in Treatment of Osteochondral Lesion of the Talus
NA
Active, not recruiting
20 participants
Started: Oct 14, 2021 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT05074160
OCS Liver Perfusion (OLP) Post-Approval Registry
N/A
Active, not recruiting
166 participants
Started: Oct 14, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
9 locations
NCT05083169
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
PHASE3
Active, not recruiting
587 participants
Started: Oct 14, 2021 · Completed: Dec 8, 2028
1 condition
1 sponsor
174 locations
NCT04656210
Myotonic Dystrophy - Vascular and Cognition
N/A
Active, not recruiting
85 participants
Started: Oct 14, 2021 · Completed: Jan 31, 2029
3 conditions
1 sponsor
1 location
NCT05030506
A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)
PHASE1
Active, not recruiting
45 participants
Started: Oct 13, 2021 · Completed: Oct 21, 2026
1 condition
1 sponsor
5 locations
NCT04274426
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
PHASE2
Active, not recruiting
136 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
19 locations
NCT04948333
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
PHASE3
Active, not recruiting
199 participants
Started: Oct 13, 2021 · Completed: Feb 3, 2026
1 condition
1 sponsor
48 locations
NCT04923035
Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) Implementation
N/A
Active, not recruiting
1,010 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2024
2 conditions
6 sponsors
3 locations
NCT05025800
ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
47 participants
Started: Oct 13, 2021 · Completed: Mar 10, 2026
20 conditions
1 sponsor
1 location
Previous
1
More pages
212
213
214
215
216
217
218
More pages
431
Next